» Articles » PMID: 14963157

Assembly Properties of the Human Immunodeficiency Virus Type 1 CA Protein

Overview
Journal J Virol
Date 2004 Feb 14
PMID 14963157
Citations 185
Authors
Affiliations
Soon will be listed here.
Abstract

During retroviral maturation, the CA protein oligomerizes to form a closed capsid that surrounds the viral genome. We have previously identified a series of deleterious surface mutations within human immunodeficiency virus type 1 (HIV-1) CA that alter infectivity, replication, and assembly in vivo. For this study, 27 recombinant CA proteins harboring 34 different mutations were tested for the ability to assemble into helical cylinders in vitro. These cylinders are composed of CA hexamers and are structural models for the mature viral capsid. Mutations that diminished CA assembly clustered within helices 1 and 2 in the N-terminal domain of CA and within the crystallographically defined dimer interface in the CA C-terminal domain. These mutations demonstrate the importance of these regions for CA cylinder production and, by analogy, mature capsid assembly. One CA mutant (R18A) assembled into cylinders, cones, and spheres. We suggest that these capsid shapes occur because the R18A mutation alters the frequency at which pentamers are incorporated into the hexagonal lattice. The fact that a single CA protein can simultaneously form all three known retroviral capsid morphologies supports the idea that these structures are organized on similar lattices and differ only in the distribution of 12 pentamers that allow them to close. In further support of this model, we demonstrate that the considerable morphological variation seen for conical HIV-1 capsids can be recapitulated in idealized capsid models by altering the distribution of pentamers.

Citing Articles

Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing.

Scott T, Arnold L, Powers J, McCann D, Rowe A, Christensen D PLoS Pathog. 2025; 21(1):e1012206.

PMID: 39874383 PMC: 11793794. DOI: 10.1371/journal.ppat.1012206.


The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir.

Huang S, Briganti L, Annamalai A, Greenwood J, Shkriabai N, Haney R PLoS Pathog. 2025; 21(1):e1012862.

PMID: 39869652 PMC: 11892807. DOI: 10.1371/journal.ppat.1012862.


IP6, PF74 affect HIV-1 capsid stability through modulation of hexamer-hexamer tilt angle preference.

Garza C, Holcomb M, Santos-Martins D, Torbett B, Forli S Biophys J. 2024; 124(2):417-427.

PMID: 39690744 PMC: 11788498. DOI: 10.1016/j.bpj.2024.12.016.


Determinants in the HTLV-1 Capsid Major Homology Region that are Critical for Virus Particle Assembly.

Yang H, Arndt W, Zhang W, Mansky L J Mol Biol. 2024; 436(24):168851.

PMID: 39505063 PMC: 11637902. DOI: 10.1016/j.jmb.2024.168851.


Structural Basis for Alternative Self-Assembly Pathways Leading to Different Human Immunodeficiency Virus Capsid-Like Nanoparticles.

Escrig J, Marcos-Alcalde I, Dominguez-Zotes S, Abia D, Gomez-Puertas P, Valbuena A ACS Nano. 2024; 18(40):27465-27478.

PMID: 39329375 PMC: 11587947. DOI: 10.1021/acsnano.4c07948.


References
1.
MOODY M . Geometry of phage head construction. J Mol Biol. 1999; 293(2):401-33. DOI: 10.1006/jmbi.1999.3011. View

2.
Gamble T, Yoo S, Vajdos F, von Schwedler U, Worthylake D, Wang H . Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 1997; 278(5339):849-53. DOI: 10.1126/science.278.5339.849. View

3.
Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich H . Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol. 2000; 74(3):1168-77. PMC: 111451. DOI: 10.1128/jvi.74.3.1168-1177.2000. View

4.
Campos-Olivas R, Newman J, Summers M . Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J Mol Biol. 2000; 296(2):633-49. DOI: 10.1006/jmbi.1999.3475. View

5.
Accola M, Strack B, Gottlinger H . Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol. 2000; 74(12):5395-402. PMC: 112023. DOI: 10.1128/jvi.74.12.5395-5402.2000. View